Literature DB >> 1828625

Effectiveness of nonsurgical treatment for idiopathic scoliosis. Overview of available evidence.

F A Focarile1, A Bonaldi, M A Giarolo, U Ferrari, E Zilioli, C Ottaviani.   

Abstract

To define further the effectiveness of nonsurgical therapy for idiopathic scoliosis, predefined criteria were established for selection and data retrieval from studies of therapy and natural history, and the results were synthesized quantitatively. Only studies of patients with no more than a 50 degree Cobb angle scoliosis were considered. Twenty-four reports were eligible. There was a fivefold proportion of failures among patients with scoliosis greater than 30 degrees at the start of therapy but no difference in progression between different kinds of nonsurgical therapies or between treated and untreated patients; these were the main findings of this quantitative analysis. These data cannot be used to prove the effectiveness or ineffectiveness of nonsurgical therapy for idiopathic scoliosis, and experimental controlled studies of different therapies seem to be justified both on ethical and scientific grounds. The findings of this overview can be used for their planning.

Entities:  

Mesh:

Year:  1991        PMID: 1828625     DOI: 10.1097/00007632-199104000-00001

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  13 in total

1.  Design of the Bracing in Adolescent Idiopathic Scoliosis Trial (BrAIST).

Authors:  Stuart L Weinstein; Lori A Dolan; James G Wright; Matthew B Dobbs
Journal:  Spine (Phila Pa 1976)       Date:  2013-10-01       Impact factor: 3.468

2.  [Compliance as a prognostic factor in the treatment of idiopathic scoliosis].

Authors:  J Seifert; A Selle; C Flieger; K P Günther
Journal:  Orthopade       Date:  2009-02       Impact factor: 1.087

3.  Results of brace treatment of adolescent idiopathic scoliosis in boys compared with girls: a retrospective study of 102 patients treated with the Boston brace.

Authors:  Timo Yrjönen; Mauno Ylikoski; Dietrich Schlenzka; Mikko Poussa
Journal:  Eur Spine J       Date:  2006-08-15       Impact factor: 3.134

4.  Effects of bracing in adolescents with idiopathic scoliosis.

Authors:  Stuart L Weinstein; Lori A Dolan; James G Wright; Matthew B Dobbs
Journal:  N Engl J Med       Date:  2013-09-19       Impact factor: 91.245

5.  Spinal deformities rehabilitation - state of the art review.

Authors:  Hans-Rudolf Weiss
Journal:  Scoliosis       Date:  2010-12-24

6.  2011 SOSORT guidelines: Orthopaedic and Rehabilitation treatment of idiopathic scoliosis during growth.

Authors:  Stefano Negrini; Angelo G Aulisa; Lorenzo Aulisa; Alin B Circo; Jean Claude de Mauroy; Jacek Durmala; Theodoros B Grivas; Patrick Knott; Tomasz Kotwicki; Toru Maruyama; Silvia Minozzi; Joseph P O'Brien; Dimitris Papadopoulos; Manuel Rigo; Charles H Rivard; Michele Romano; James H Wynne; Monica Villagrasa; Hans-Rudolf Weiss; Fabio Zaina
Journal:  Scoliosis       Date:  2012-01-20

7.  Physical exercises in the treatment of idiopathic scoliosis at risk of brace treatment -- SOSORT consensus paper 2005.

Authors:  Hans-Rudolf Weiss; Stefano Negrini; Martha C Hawes; Manuel Rigo; Tomasz Kotwicki; Theodoros B Grivas; Toru Maruyama
Journal:  Scoliosis       Date:  2006-05-11

8.  Effects of Swiss ball exercise and resistance exercise on respiratory function and trunk control ability in patients with scoliosis.

Authors:  Jwa Jun Kim; Gui Bin Song; Eun Cho Park
Journal:  J Phys Ther Sci       Date:  2015-06-30

9.  Clinical effect of continuous corrective force delivery in the non-operative treatment of idiopathic scoliosis: a prospective cohort study of the TriaC-brace.

Authors:  Gerben J Bulthuis; Albert G Veldhuizen; Gert Nijenbanning
Journal:  Eur Spine J       Date:  2007-10-10       Impact factor: 3.134

10.  Bracing patients with idiopathic scoliosis: design of the Dutch randomized controlled treatment trial.

Authors:  Eveline M Bunge; Harry J de Koning
Journal:  BMC Musculoskelet Disord       Date:  2008-04-22       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.